Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in mice and humans

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 5, 2015, Pages E688-E696

  Todd, Jennifer N ^a,b,d   Poon, Wenny ^f   Lyssenko, Valeriya ^f,g   Groop, Leif ^f,h   Nichols, Brendan ^c   Wilmot, Michael ^c   Robson, Simon ^b,c   Enjyoji, Keiichi ^b,c   Herman, Mark A ^b,c   Hu, Cheng ⁱ   Zhang, Rong ⁱ   Jia, Weiping ⁱ   Ma, Ronald ^j   Florez, Jose C ^b,d,e   Friedman, David J ^b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g STENO DIABETES CENTER   (Denmark)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ SHANGHAI JIAO TONG UNIVERSITY   (China)

^j CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL; P2RX7 PROTEIN, HUMAN; P2RX7 PROTEIN, MOUSE; PURINERGIC P2X7 RECEPTOR;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MISSENSE MUTATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; P2RX7 GENE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; B LYMPHOCYTE; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS;

MUS;

ALLELES; ANIMALS; B-LYMPHOCYTES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HOMEOSTASIS; HUMANS; MALE; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PURINERGIC P2X7;

EID: 84929302596     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4160     Document Type: Article

References (40)

1. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981-990.
2. Vassort G. Adenosine 5ô-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev. 2001;81(2):767-806.
3. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease. Nature. 2006;442(7102):527-532.
4. Boeynaems JM, Communi D, Gonzalez NS, Robaye B. Overview of the P2 receptors. Semin Thromb Hemost. 2005;31(2):139-149.
5. Burnstock G. Purinergic signalling-an overview. Novartis Found Symp. 2006;276:26-48; discussion 48-57, 275-281.
6. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev. 2006;58(1):58-86.
7. Robson SC, Sevigny J, Zimmermann H. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal. 2006;2(2):409-430.
8. Leon C, Freund M, Latchoumanin O, et al. The P2Y(1) receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice. Purinergic Signal. 2005;1(2):145-151.
9. Glas R, Sauter NS, Schulthess FT, Shu L, Oberholzer J, Maedler K. Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and β cell function and survival. Diabetologia. 2009; 52(8):1579-1588.
10. Petit P, Lajoix AD, Gross R. P2 purinergic signalling in the pancreatic β-cell: control of insulin secretion and pharmacology. Eur J Pharmaceut Sci. 2009;37(2):67-75.
11. Jacques-Silva MC, Correa-Medina M, Cabrera O, et al. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic β cell. Proc Natl Acad Sci USA. 2010;107(14):6465-6470.
12. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105-116.
13. Saxena R, Elbers CC, Guo Y, et al. Large-scale gene-centric metaanalysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012;90(3):410-425.
14. Strawbridge RJ, Dupuis J, Prokopenko I, et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes. 2011;60:2624-2634.
15. Nyholt DR. A simple correction for multiple testing for SNPs in linkage disequilibrium with each other. Am J Hum Genet. 2004; 74(4):765-769.
16. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity. 2005;95(3):221-227.
17. Isomaa B, Forsen B, Lahti K, et al. A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia. 2010; 53(8):1709-1713.
18. Adriouch S, Dox C, Welge V, Seman M, Koch-Nolte F, Haag F. Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J Immunol. 2002; 169(8):4108-4112.
19. Heikkinen S, Argmann CA, Champy MF, Auwerx J. Evaluation of glucose homeostasis. Curr Protoc Mol Biol. 2007;Chapter 29:Unit 29B3.
20. Almind K, Kahn CR. Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes. 2004;53(12):3274-3285.
21. Le Stunff H, Auger R, Kanellopoulos J, Raymond MN. The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J Biol Chem. 2004;279(17):16918-16926.
22. Stokes L, Fuller SJ, Sluyter R, Skarratt KK, Gu BJ, Wiley JS. Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1βsecretion. FASEB J. 2010;24(8):2916-2927.
23. Denlinger LC, Coursin DB, Schell K, et al. Human P2X7 pore function predicts allele linkage disequilibrium. Clin Chem. 2006;52(6): 995-1004.
24. rd Annual Scientific Sessions of the American Diabetes Association; June 21-25, 2013; Chicago, IL.
25. Ma RC, Hu C, Tam CH, et al. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia. 2013;56(6):1291-1305.
26. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747-753.
27. Pe'er I, Yelensky R, Altshuler D, Daly MJ. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol. 2008;32(4):381-385.
28. Surprenant A, North RA. Signaling at purinergic P2X receptors. Annu Rev Physiol. 2009;71:333-359.
29. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science. 1996;272(5262):735-738.
30. Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor. EMBO J. 2006;25(21):5071-5082.
31. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscl Thromb Vasc Biol. 2002;22(3):364-373.
32. Mariathasan S, Weiss DS, Newton K, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006; 440(7081):228-232.
33. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of β-cell function: The hyperbolic correction. Diabetes. 2002;51(90001):S212-220.
34. Baratta R, Rossetti P, Prudente S, et al. Role of the ENPP1 K121Q polymorphism in glucose homeostasis. Diabetes. 2008;57(12): 3360-3364.
35. Stolerman ES, Manning AK, McAteer JB, et al. Haplotype structure of the ENPP1 gene and nominal association of the K121Q polymorphism with glycemic traits in the Framingham Heart Study. Diabetes. 2008;57(7):1971-1977.
36. Goldfine ID, Maddux BA, Youngren JF, et al. The role of membrane glycoprotein PC-1/ENPP1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev. 2008;29(1):62-75.
37. Meyre D, Bouatia-Naji N, Tounian A, Samson C, Froguel P. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet. 2005;37(8):863-867.
38. Maddux BA, Chang YN, Accili D, McGuinness OP, Youngren JF, Goldfine ID. Overexpression of the insulin receptor inhibitor PC- 1/ENPP1 induces insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab. 2006;290(4):E746-E749.
39. Chin CN, Dallas-Yang Q, Liu F, et al. Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity. Eur J Pharmacol. 2009;606(1-3):17-24.
40. Friedman DJ, Talbert ME, Bowden DW, et al. Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease. Diabetes. 2009;58(4):999-1006.